 | • レポートコード：QYR9ST04433 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、認知症および運動障害の治療の世界市場について調査・分析し、認知症および運動障害の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（MAO阻害剤（モノアミンオキシダーゼ）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤）、用途別（ブランド薬、一般薬、適応外薬）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の認知症および運動障害の治療市場動向 ・主要企業別マーケットシェア ・認知症および運動障害の治療の種類別市場規模2014-2019 （MAO阻害剤（モノアミンオキシダーゼ）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤） ・認知症および運動障害の治療の用途別市場規模2014-2019 （ブランド薬、一般薬、適応外薬） ・認知症および運動障害の治療の北米市場：主要企業・種類別/用途別市場規模 ・認知症および運動障害の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・認知症および運動障害の治療の中国市場：主要企業・種類別/用途別市場規模 ・認知症および運動障害の治療の日本国内市場：主要企業・種類別/用途別市場規模 ・認知症および運動障害の治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・認知症および運動障害の治療のインド市場：主要企業・種類別/用途別市場規模 ・認知症および運動障害の治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Allergan、Eisai、Novartis、Teva Pharmaceutical Industries、Amgen、Pfizer、UCB、H. Lundbeck、F. Hoffmann-La Roche、Eli Lilly） ・認知症および運動障害の治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia.The treatment for dementia is conducted through therapeutic approaches that provide symptomatic relief as the drugs intended for the treatment only treat the symptoms. The existing drugs in the market are unable to attack the underlying cause of the disease and prolong the treatment cost and time duration. This will in turn increase the demand for DMD since it will safely modify the progression of a disease.
The market is highly competitive and fragmented due to the presence of several large players that have launched successful drugs. The expiry of the patents significantly affects the performance of the manufacturers. Geographical presence, stable supply chain logistics, patent expiry, and new approvals of already established/expired drugs for additional indications are some of the major factors the manufacturers usually compete on.
The Americas is home to a large patient pool and a witnessing a rise in the geriatric population. Factors such as the focus on the government of USA towards taking initiatives to develop drugs for dementia and movement disorder (DAMD) that expands the access to effective treatment regimen for DAMD will fuel the market’s growth prospects in this region.
In 2018, the global Dementia and Movement Disorder Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Dementia and Movement Disorder Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dementia and Movement Disorder Treatment development in United States, Europe and China.
The key players covered in this study
Allergan
Eisai
Novartis
Teva Pharmaceutical Industries
Amgen
Pfizer
UCB
H. Lundbeck
F. Hoffmann-La Roche
Eli Lilly
Market segment by Type, the product can be split into
MAO inhibitors (monoamine oxidase)
AChE inhibitors (acetylcholinesterase)
Glutamate inhibitors
Market segment by Application, split into
Branded drugs
Generic drugs
Off-label drugs
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Dementia and Movement Disorder Treatment status, future forecast, growth opportunity, key market and key players.
To present the Dementia and Movement Disorder Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Dementia and Movement Disorder Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dementia and Movement Disorder Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 MAO inhibitors (monoamine oxidase)
1.4.3 AChE inhibitors (acetylcholinesterase)
1.4.4 Glutamate inhibitors
1.5 Market by Application
1.5.1 Global Dementia and Movement Disorder Treatment Market Share by Application (2014-2025)
1.5.2 Branded drugs
1.5.3 Generic drugs
1.5.4 Off-label drugs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Dementia and Movement Disorder Treatment Market Size
2.2 Dementia and Movement Disorder Treatment Growth Trends by Regions
2.2.1 Dementia and Movement Disorder Treatment Market Size by Regions (2014-2025)
2.2.2 Dementia and Movement Disorder Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Dementia and Movement Disorder Treatment Market Size by Manufacturers
3.1.1 Global Dementia and Movement Disorder Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Dementia and Movement Disorder Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dementia and Movement Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Dementia and Movement Disorder Treatment Key Players Head office and Area Served
3.3 Key Players Dementia and Movement Disorder Treatment Product/Solution/Service
3.4 Date of Enter into Dementia and Movement Disorder Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Dementia and Movement Disorder Treatment Market Size by Type (2014-2019)
4.2 Global Dementia and Movement Disorder Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Dementia and Movement Disorder Treatment Market Size (2014-2019)
5.2 Dementia and Movement Disorder Treatment Key Players in United States
5.3 United States Dementia and Movement Disorder Treatment Market Size by Type
5.4 United States Dementia and Movement Disorder Treatment Market Size by Application
6 Europe
6.1 Europe Dementia and Movement Disorder Treatment Market Size (2014-2019)
6.2 Dementia and Movement Disorder Treatment Key Players in Europe
6.3 Europe Dementia and Movement Disorder Treatment Market Size by Type
6.4 Europe Dementia and Movement Disorder Treatment Market Size by Application
7 China
7.1 China Dementia and Movement Disorder Treatment Market Size (2014-2019)
7.2 Dementia and Movement Disorder Treatment Key Players in China
7.3 China Dementia and Movement Disorder Treatment Market Size by Type
7.4 China Dementia and Movement Disorder Treatment Market Size by Application
8 Japan
8.1 Japan Dementia and Movement Disorder Treatment Market Size (2014-2019)
8.2 Dementia and Movement Disorder Treatment Key Players in Japan
8.3 Japan Dementia and Movement Disorder Treatment Market Size by Type
8.4 Japan Dementia and Movement Disorder Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Dementia and Movement Disorder Treatment Market Size (2014-2019)
9.2 Dementia and Movement Disorder Treatment Key Players in Southeast Asia
9.3 Southeast Asia Dementia and Movement Disorder Treatment Market Size by Type
9.4 Southeast Asia Dementia and Movement Disorder Treatment Market Size by Application
10 India
10.1 India Dementia and Movement Disorder Treatment Market Size (2014-2019)
10.2 Dementia and Movement Disorder Treatment Key Players in India
10.3 India Dementia and Movement Disorder Treatment Market Size by Type
10.4 India Dementia and Movement Disorder Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Dementia and Movement Disorder Treatment Market Size (2014-2019)
11.2 Dementia and Movement Disorder Treatment Key Players in Central & South America
11.3 Central & South America Dementia and Movement Disorder Treatment Market Size by Type
11.4 Central & South America Dementia and Movement Disorder Treatment Market Size by Application
12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dementia and Movement Disorder Treatment Introduction
12.1.4 Allergan Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.1.5 Allergan Recent Development
12.2 Eisai
12.2.1 Eisai Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dementia and Movement Disorder Treatment Introduction
12.2.4 Eisai Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.2.5 Eisai Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dementia and Movement Disorder Treatment Introduction
12.3.4 Novartis Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Teva Pharmaceutical Industries
12.4.1 Teva Pharmaceutical Industries Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dementia and Movement Disorder Treatment Introduction
12.4.4 Teva Pharmaceutical Industries Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.4.5 Teva Pharmaceutical Industries Recent Development
12.5 Amgen
12.5.1 Amgen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dementia and Movement Disorder Treatment Introduction
12.5.4 Amgen Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.5.5 Amgen Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dementia and Movement Disorder Treatment Introduction
12.6.4 Pfizer Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 UCB
12.7.1 UCB Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dementia and Movement Disorder Treatment Introduction
12.7.4 UCB Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.7.5 UCB Recent Development
12.8 H. Lundbeck
12.8.1 H. Lundbeck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dementia and Movement Disorder Treatment Introduction
12.8.4 H. Lundbeck Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.8.5 H. Lundbeck Recent Development
12.9 F. Hoffmann-La Roche
12.9.1 F. Hoffmann-La Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dementia and Movement Disorder Treatment Introduction
12.9.4 F. Hoffmann-La Roche Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.9.5 F. Hoffmann-La Roche Recent Development
12.10 Eli Lilly
12.10.1 Eli Lilly Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dementia and Movement Disorder Treatment Introduction
12.10.4 Eli Lilly Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)
12.10.5 Eli Lilly Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Dementia and Movement Disorder Treatment Key Market Segments
Table Key Players Dementia and Movement Disorder Treatment Covered
Table Global Dementia and Movement Disorder Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Dementia and Movement Disorder Treatment Market Size Market Share by Type 2014-2025
Figure MAO inhibitors (monoamine oxidase) Figures
Table Key Players of MAO inhibitors (monoamine oxidase)
Figure AChE inhibitors (acetylcholinesterase) Figures
Table Key Players of AChE inhibitors (acetylcholinesterase)
Figure Glutamate inhibitors Figures
Table Key Players of Glutamate inhibitors
Table Global Dementia and Movement Disorder Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Branded drugs Case Studies
Figure Generic drugs Case Studies
Figure Off-label drugs Case Studies
Figure Dementia and Movement Disorder Treatment Report Years Considered
Table Global Dementia and Movement Disorder Treatment Market Size 2014-2025 (Million US$)
Figure Global Dementia and Movement Disorder Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dementia and Movement Disorder Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Dementia and Movement Disorder Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Dementia and Movement Disorder Treatment Market Share by Regions 2014-2019
Figure Global Dementia and Movement Disorder Treatment Market Share by Regions 2014-2019
Figure Global Dementia and Movement Disorder Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Dementia and Movement Disorder Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Dementia and Movement Disorder Treatment Market Share by Manufacturers (2014-2019)
Figure Global Dementia and Movement Disorder Treatment Market Share by Manufacturers in 2018
Table Global Dementia and Movement Disorder Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dementia and Movement Disorder Treatment Product/Solution/Service
Table Date of Enter into Dementia and Movement Disorder Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dementia and Movement Disorder Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Dementia and Movement Disorder Treatment Market Size Share by Type (2014-2019)
Figure Global Dementia and Movement Disorder Treatment Market Size Market Share by Type (2014-2019)
Table Global Dementia and Movement Disorder Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Dementia and Movement Disorder Treatment Market Size Share by Application (2014-2019)
Figure Global Dementia and Movement Disorder Treatment Market Size Market Share by Application (2014-2019)
Figure Global Dementia and Movement Disorder Treatment Revenue Market Share by Application in 2018
Figure United States Dementia and Movement Disorder Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Dementia and Movement Disorder Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Dementia and Movement Disorder Treatment Market Share (2018-2019)
Table United States Dementia and Movement Disorder Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Dementia and Movement Disorder Treatment Market Share by Type (2014-2019)
Table United States Dementia and Movement Disorder Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Dementia and Movement Disorder Treatment Market Share by Application (2014-2019)
Figure Europe Dementia and Movement Disorder Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Dementia and Movement Disorder Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Dementia and Movement Disorder Treatment Market Share (2018-2019)
Table Europe Dementia and Movement Disorder Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Dementia and Movement Disorder Treatment Market Share by Type (2014-2019)
Table Europe Dementia and Movement Disorder Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Dementia and Movement Disorder Treatment Market Share by Application (2014-2019)
Figure China Dementia and Movement Disorder Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Dementia and Movement Disorder Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Dementia and Movement Disorder Treatment Market Share (2018-2019)
Table China Dementia and Movement Disorder Treatment Market Size by Type (2014-20189) (Million US$)
Table China Dementia and Movement Disorder Treatment Market Share by Type (2014-2019)
Table China Dementia and Movement Disorder Treatment Market Size by Application (2014-2019) (Million US$)
Table China Dementia and Movement Disorder Treatment Market Share by Application (2014-2019)
Figure Japan Dementia and Movement Disorder Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Dementia and Movement Disorder Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Dementia and Movement Disorder Treatment Market Share (2018-2019)
Table Japan Dementia and Movement Disorder Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Dementia and Movement Disorder Treatment Market Share by Type (2014-2019)
Table Japan Dementia and Movement Disorder Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Dementia and Movement Disorder Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Dementia and Movement Disorder Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dementia and Movement Disorder Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dementia and Movement Disorder Treatment Market Share (2018-2019)
Table Southeast Asia Dementia and Movement Disorder Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Dementia and Movement Disorder Treatment Market Share by Type (2014-2019)
Table Southeast Asia Dementia and Movement Disorder Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Dementia and Movement Disorder Treatment Market Share by Application (2014-2019)
Figure India Dementia and Movement Disorder Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Dementia and Movement Disorder Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Dementia and Movement Disorder Treatment Market Share (2018-2019)
Table India Dementia and Movement Disorder Treatment Market Size by Type (2014-2019) (Million US$)
Table India Dementia and Movement Disorder Treatment Market Share by Type (2014-2019)
Table India Dementia and Movement Disorder Treatment Market Size by Application (2014-2019) (Million US$)
Table India Dementia and Movement Disorder Treatment Market Share by Application (2014-2019)
Figure Central & South America Dementia and Movement Disorder Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dementia and Movement Disorder Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dementia and Movement Disorder Treatment Market Share (2018-2019)
Table Central & South America Dementia and Movement Disorder Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Dementia and Movement Disorder Treatment Market Share by Type (2014-2019)
Table Central & South America Dementia and Movement Disorder Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Dementia and Movement Disorder Treatment Market Share by Application (2014-2019)
Table Allergan Company Details
Table Allergan Revenue in Dementia and Movement Disorder Treatment Business (2014-2019) (Million US$)
Figure Allergan Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table Allergan Recent Development
Table Eisai Company Details
Table Eisai Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table Eisai Recent Development
Table Novartis Company Details
Table Novartis Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table Novartis Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Amgen Company Details
Table Amgen Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table Amgen Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table Pfizer Recent Development
Table UCB Company Details
Table UCB Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)(Million US$)
Figure UCB Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table UCB Recent Development
Table H. Lundbeck Company Details
Table H. Lundbeck Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)(Million US$)
Figure H. Lundbeck Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table H. Lundbeck Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Dementia and Movement Disorder Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Global Dementia and Movement Disorder Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Dementia and Movement Disorder Treatment Market Size Share by Regions (2019-2025)
Figure Global Dementia and Movement Disorder Treatment Market Size Share by Regions in 2025
Figure United States Dementia and Movement Disorder Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dementia and Movement Disorder Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Dementia and Movement Disorder Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dementia and Movement Disorder Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dementia and Movement Disorder Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Dementia and Movement Disorder Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dementia and Movement Disorder Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Dementia and Movement Disorder Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Dementia and Movement Disorder Treatment Market Size by Product (2019-2025)
Figure Global Dementia and Movement Disorder Treatment Market Size by Product in 2025
Table Global Dementia and Movement Disorder Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Dementia and Movement Disorder Treatment Market Size by Application (2019-2025)
Figure Global Dementia and Movement Disorder Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
認知症薬の世界市場：インサイト・予測 The global Dementia Drugs market is valued at 13900 million US$ in 2018 and will reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dementia Drugs market based on company, product ty…- 双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…
- 双極性障害の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity le…
- 抗うつ薬の世界市場：インサイト・予測 Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps i…
- 胎児アルコールスペクトラム障害治療の世界市場：市場規模・現状・予測 Fetal alcohol spectrum disorder are the group of conditions occurring in new born with a wide range of disabilities.Fetal alcohol spectrum disorder treatment market is an evolving market owing to the gradual change in the lifestyle and increased alcohol consumption by pregnant women, eventually incr…